Buyer's Guide to Healthcare Autonomy Platforms
Register to view
Fill in the form below to watch the video.
About this recording
A CHIME-endorsed framework for evaluating platforms that claim to execute autonomous workflows.
The questions that separate genuine context infrastructure from context-poor automation dressed up as autonomy — including how to approach build versus buy, platform versus point solution, and contract structures that align to outcomes.
Who should attend
Health system CIOs, CMOs, and digital and AI strategy leaders who evaluate or govern AI platform purchases. Useful for anyone sitting on the build-versus-buy decision or negotiating outcome-based contracts.
Who you'll hear from
Benjamin Cassity
KLAS Research
Director - Research and Strategy (VBC, AI)
EJ McMahon, MD, MBA, FCAP
Capital Health System
SVP and CMO
Amy Stevens
Innovaccer
Market President - Sales
Allison Shimooka
Innovaccer
Market President - Provider Growth
How AI in RCM Is Being Deployed in Practice, Not in Theory
McLaren Healthcare is not running a pilot. A look at what autonomous RCM deployment actually looks like inside a large health system, including what was harder than expected.
The AI Opportunity in Utilization Management
Prior authorization is under regulatory pressure and operational strain. Where AI is delivering genuine value in utilization management — and what separates successful deployments from those that create new compliance and clinical risk.
Care Management at Population Scale
A care coordinator managing 200 patients gives high-touch attention to the top 5 percent; the other 95 percent drift until a hospitalization brings them back. What it takes to run care management across the full attributed population.